Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

MD vs HCA vs THC vs CYH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MD
Pediatrix Medical Group, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$1.90B
5Y Perf.+47.6%
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$95.95B
5Y Perf.+301.5%
THC
Tenet Healthcare Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$17.01B
5Y Perf.+792.1%
CYH
Community Health Systems, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$408M
5Y Perf.-8.1%

MD vs HCA vs THC vs CYH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MD logoMD
HCA logoHCA
THC logoTHC
CYH logoCYH
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$1.90B$95.95B$17.01B$408M
Revenue (TTM)$1.93B$75.60B$21.45B$21.48B
Net Income (TTM)$174M$6.78B$1.70B$-88M
Gross Margin25.5%41.5%42.8%53.7%
Operating Margin11.9%15.8%16.1%-39.8%
Forward P/E10.3x14.2x10.9x0.8x
Total Debt$660M$50.20B$13.17B$11.58B
Cash & Equiv.$375M$1.04B$2.88B$260M

MD vs HCA vs THC vs CYHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MD
HCA
THC
CYH
StockMay 20May 26Return
Pediatrix Medical G… (MD)100147.6+47.6%
HCA Healthcare, Inc. (HCA)100401.5+301.5%
Tenet Healthcare Co… (THC)100892.1+792.1%
Community Health Sy… (CYH)10091.9-8.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: MD vs HCA vs THC vs CYH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCA leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Pediatrix Medical Group, Inc. is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. CYH also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
MD
Pediatrix Medical Group, Inc.
The Quality Compounder

MD is the #2 pick in this set and the best alternative if quality and momentum is your priority.

  • 9.0% margin vs CYH's -0.4%
  • +59.8% vs CYH's -11.7%
Best for: quality and momentum
HCA
HCA Healthcare, Inc.
The Income Pick

HCA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 5 yrs, beta 0.29, yield 0.7%
  • Rev growth 7.1%, EPS growth 29.0%, 3Y rev CAGR 7.9%
  • 7.1% revenue growth vs MD's -4.9%
  • Beta 0.29 vs CYH's 1.60
Best for: income & stability and growth exposure
THC
Tenet Healthcare Corporation
The Long-Run Compounder

THC is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 5.2% 10Y total return vs HCA's 450.5%
  • Lower volatility, beta 0.71, current ratio 1.76x
  • PEG 0.33 vs HCA's 0.67
  • Beta 0.71, current ratio 1.76x
Best for: long-term compounding and sleep-well-at-night
CYH
Community Health Systems, Inc.
The Value Play

CYH is the clearest fit if your priority is value.

  • Lower P/E (0.8x vs 14.2x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthHCA logoHCA7.1% revenue growth vs MD's -4.9%
ValueCYH logoCYHLower P/E (0.8x vs 14.2x)
Quality / MarginsMD logoMD9.0% margin vs CYH's -0.4%
Stability / SafetyHCA logoHCABeta 0.29 vs CYH's 1.60
DividendsHCA logoHCA0.7% yield; 5-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)MD logoMD+59.8% vs CYH's -11.7%
Efficiency (ROA)HCA logoHCA11.3% ROA vs CYH's -0.7%, ROIC 19.9% vs -70.1%

MD vs HCA vs THC vs CYH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MDPediatrix Medical Group, Inc.
FY 2025
Health Care, Patient Service
85.2%$1.6B
Hospitals Contracts
14.2%$271M
Product and Service, Other
0.6%$12M
HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B
THCTenet Healthcare Corporation
FY 2025
Ambulatory Care
50.2%$5.2B
Hospital Operations
49.8%$5.1B
CYHCommunity Health Systems, Inc.
FY 2025
Managed Care And Other Third Party Payors
58.4%$6.0B
Medicare
21.2%$2.2B
Medicaid
19.5%$2.0B
Self Pay Revenue
0.9%$96M

MD vs HCA vs THC vs CYH — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLTHCLAGGINGCYH

Income & Cash Flow (Last 12 Months)

THC leads this category, winning 3 of 6 comparable metrics.

HCA is the larger business by revenue, generating $75.6B annually — 39.1x MD's $1.9B. MD is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to CYH's -0.4%.

MetricMD logoMDPediatrix Medical…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
RevenueTrailing 12 months$1.9B$75.6B$21.5B$21.5B
EBITDAEarnings before interest/tax$252M$15.5B$4.3B-$7.8B
Net IncomeAfter-tax profit$174M$6.8B$1.7B-$88M
Free Cash FlowCash after capex$238M$7.7B$3.3B-$200M
Gross MarginGross profit ÷ Revenue+25.5%+41.5%+42.8%+53.7%
Operating MarginEBIT ÷ Revenue+11.9%+15.8%+16.1%-39.8%
Net MarginNet income ÷ Revenue+9.0%+9.0%+7.9%-0.4%
FCF MarginFCF ÷ Revenue+12.3%+10.2%+15.6%-0.9%
Rev. Growth (YoY)Latest quarter vs prior year+3.9%+6.7%+2.8%+2.8%
EPS Growth (YoY)Latest quarter vs prior year+50.0%+44.6%+87.6%-45.2%
THC leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — THC and CYH each lead in 3 of 7 comparable metrics.

At 0.8x trailing earnings, CYH trades at a 95% valuation discount to HCA's 15.1x P/E. Adjusting for growth (PEG ratio), THC offers better value at 0.38x vs HCA's 0.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricMD logoMDPediatrix Medical…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Market CapShares × price$1.9B$95.9B$17.0B$408M
Enterprise ValueMkt cap + debt − cash$2.2B$145.1B$27.3B$11.7B
Trailing P/EPrice ÷ TTM EPS11.82x15.12x12.53x0.77x
Forward P/EPrice ÷ next-FY EPS est.10.26x14.19x10.94x
PEG RatioP/E ÷ EPS growth rate0.72x0.38x
EV / EBITDAEnterprise value multiple8.66x9.37x6.34x
Price / SalesMarket cap ÷ Revenue1.00x1.27x0.80x0.03x
Price / BookPrice ÷ Book value/share2.26x1.97x
Price / FCFMarket cap ÷ FCF7.54x12.47x6.72x1.96x
Evenly matched — THC and CYH each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

MD leads this category, winning 6 of 9 comparable metrics.

MD delivers a 20.1% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $20 for THC. MD carries lower financial leverage with a 0.76x debt-to-equity ratio, signaling a more conservative balance sheet compared to THC's 1.47x. On the Piotroski fundamental quality scale (0–9), MD scores 7/9 vs CYH's 6/9, reflecting strong financial health.

MetricMD logoMDPediatrix Medical…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
ROE (TTM)Return on equity+20.1%+19.6%
ROA (TTM)Return on assets+8.1%+11.3%+5.7%-0.7%
ROICReturn on invested capital+14.8%+19.9%+13.2%-70.1%
ROCEReturn on capital employed+13.2%+27.0%+13.8%-87.3%
Piotroski ScoreFundamental quality 0–97776
Debt / EquityFinancial leverage0.76x1.47x
Net DebtTotal debt minus cash$285M$49.2B$10.3B$11.3B
Cash & Equiv.Liquid assets$375M$1.0B$2.9B$260M
Total DebtShort + long-term debt$660M$50.2B$13.2B$11.6B
Interest CoverageEBIT ÷ Interest expense20.20x5.37x4.28x4.89x
MD leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

THC leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in THC five years ago would be worth $29,044 today (with dividends reinvested), compared to $1,902 for CYH. Over the past 12 months, MD leads with a +59.8% total return vs CYH's -11.7%. The 3-year compound annual growth rate (CAGR) favors THC at 40.7% vs CYH's -6.0% — a key indicator of consistent wealth creation.

MetricMD logoMDPediatrix Medical…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
YTD ReturnYear-to-date+7.7%-8.6%-2.7%-6.6%
1-Year ReturnPast 12 months+59.8%+19.7%+27.4%-11.7%
3-Year ReturnCumulative with dividends+67.0%+57.4%+178.5%-16.8%
5-Year ReturnCumulative with dividends-28.6%+109.7%+190.4%-81.0%
10-Year ReturnCumulative with dividends-67.1%+450.5%+523.4%-80.3%
CAGR (3Y)Annualised 3-year return+18.6%+16.3%+40.7%-6.0%
THC leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MD and HCA each lead in 1 of 2 comparable metrics.

HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than CYH's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MD currently trades 91.8% from its 52-week high vs CYH's 64.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMD logoMDPediatrix Medical…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Beta (5Y)Sensitivity to S&P 5000.73x0.29x0.71x1.60x
52-Week HighHighest price in past year$24.99$556.52$247.21$4.47
52-Week LowLowest price in past year$11.84$330.00$146.60$2.38
% of 52W HighCurrent price vs 52-week peak+91.8%+77.1%+78.5%+64.8%
RSI (14)Momentum oscillator 0–10051.330.852.946.4
Avg Volume (50D)Average daily shares traded772K1000K1.2M1.6M
Evenly matched — MD and HCA each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCA leads this category, winning 1 of 1 comparable metric.

Analyst consensus: MD as "Hold", HCA as "Buy", THC as "Buy", CYH as "Hold". Consensus price targets imply 38.1% upside for THC (target: $268) vs -3.0% for MD (target: $22). HCA is the only dividend payer here at 0.69% yield — a key consideration for income-focused portfolios.

MetricMD logoMDPediatrix Medical…HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$22.25$527.45$268.00$2.93
# AnalystsCovering analysts33463237
Dividend YieldAnnual dividend ÷ price+0.7%
Dividend StreakConsecutive years of raises502
Dividend / ShareAnnual DPS$2.94
Buyback YieldShare repurchases ÷ mkt cap+4.6%+10.5%+8.4%+0.5%
HCA leads this category, winning 1 of 1 comparable metric.
Key Takeaway

THC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MD leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallTenet Healthcare Corporation (THC)Leads 2 of 6 categories
Loading custom metrics...

MD vs HCA vs THC vs CYH: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is MD or HCA or THC or CYH a better buy right now?

For growth investors, HCA Healthcare, Inc.

(HCA) is the stronger pick with 7. 1% revenue growth year-over-year, versus -4. 9% for Pediatrix Medical Group, Inc. (MD). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate HCA Healthcare, Inc. (HCA) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MD or HCA or THC or CYH?

On trailing P/E, Community Health Systems, Inc.

(CYH) is the cheapest at 0. 8x versus HCA Healthcare, Inc. at 15. 1x. On forward P/E, Pediatrix Medical Group, Inc. is actually cheaper at 10. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tenet Healthcare Corporation wins at 0. 33x versus HCA Healthcare, Inc. 's 0. 67x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — MD or HCA or THC or CYH?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +190.

4%, compared to -81. 0% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: THC returned +523. 4% versus CYH's -80. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MD or HCA or THC or CYH?

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 29β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 460% more volatile than HCA relative to the S&P 500. On balance sheet safety, Pediatrix Medical Group, Inc. (MD) carries a lower debt/equity ratio of 76% versus 147% for Tenet Healthcare Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — MD or HCA or THC or CYH?

By revenue growth (latest reported year), HCA Healthcare, Inc.

(HCA) is pulling ahead at 7. 1% versus -4. 9% for Pediatrix Medical Group, Inc. (MD). On earnings-per-share growth, the picture is similar: Pediatrix Medical Group, Inc. grew EPS 263. 0% year-over-year, compared to -52. 6% for Tenet Healthcare Corporation. Over a 3-year CAGR, HCA leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MD or HCA or THC or CYH?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 4. 1% for Community Health Systems, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16. 1% versus -79. 4% for CYH. At the gross margin level — before operating expenses — THC leads at 82. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MD or HCA or THC or CYH more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Tenet Healthcare Corporation (THC) is the more undervalued stock at a PEG of 0. 33x versus HCA Healthcare, Inc. 's 0. 67x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Pediatrix Medical Group, Inc. (MD) trades at 10. 3x forward P/E versus 14. 2x for HCA Healthcare, Inc. — 3. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for THC: 38. 1% to $268. 00.

08

Which pays a better dividend — MD or HCA or THC or CYH?

In this comparison, HCA (0.

7% yield) pays a dividend. MD, THC, CYH do not pay a meaningful dividend and should not be held primarily for income.

09

Is MD or HCA or THC or CYH better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +450. 5% 10Y return). Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCA: +450. 5%, CYH: -80. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MD and HCA and THC and CYH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

HCA pays a dividend while MD, THC, CYH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MD

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

CYH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 142%
  • Gross Margin > 32%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MD and HCA and THC and CYH on the metrics below

Revenue Growth>
%
(MD: 3.9% · HCA: 6.7%)
Net Margin>
%
(MD: 9.0% · HCA: 9.0%)
P/E Ratio<
x
(MD: 11.8x · HCA: 15.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.